Moolec Science S.A. (MLEC)
Moolec Science S.A. operates in the Biotechnology industry of the Healthcare sector, headquartered in Grand Cayman, LU, KY. The stock last traded at $6.92, down 2.26% on the session, giving a market capitalisation of $5.0M. On trailing twelve-month figures it carries a trailing P/E of -0.03, a net margin of -33.4%. Its beta of 0.26 implies it has historically moved less than the broad market.
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands.
Moolec Science S.A. is most often compared with the following Healthcare names: